Literature DB >> 22045806

Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.

Suzanne T Thomas1, Brian C VanderVen2, David R Sherman3, David G Russell4, Nicole S Sampson5.   

Abstract

Mycobacterium tuberculosis, the bacterium that causes tuberculosis, imports and metabolizes host cholesterol during infection. This ability is important in the chronic phase of infection. Here we investigate the role of the intracellular growth operon (igr), which has previously been identified as having a cholesterol-sensitive phenotype in vitro and which is important for intracellular growth of the mycobacteria. We have employed isotopically labeled low density lipoproteins containing either [1,7,15,22,26-(14)C]cholesterol or [1,7,15,22,26-(13)C]cholesterol and high resolution LC/MS as tools to profile the cholesterol-derived metabolome of an igr operon-disrupted mutant (Δigr) of M. tuberculosis. A partially metabolized cholesterol species accumulated in the Δigr knock-out strain that was absent in the complemented and parental wild-type strains. Structural elucidation by multidimensional 1H and 13C NMR spectroscopy revealed the accumulated metabolite to be methyl 1β-(2'-propanoate)-3aα-H-4α-(3'-propanoic acid)-7aβ-methylhexahydro-5-indanone. Heterologously expressed and purified FadE28-FadE29, an acyl-CoA dehydrogenase encoded by the igr operon, catalyzes the dehydrogenation of 2'-propanoyl-CoA ester side chains in substrates with structures analogous to the characterized metabolite. Based on the structure of the isolated metabolite, enzyme activity, and bioinformatic annotations, we assign the primary function of the igr operon to be degradation of the 2'-propanoate side chain. Therefore, the igr operon is necessary to completely metabolize the side chain of cholesterol metabolites.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045806      PMCID: PMC3243565          DOI: 10.1074/jbc.M111.313643

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Studies on the biosynthesis of cholesterol. XV. Mechanism of squalene biosynthesis from farnesyl pyrophosphate and from mevalonate.

Authors:  G POPJAK; W S GOODMAN; J W CORNFORTH; R H CORNFORTH; R RYHAGE
Journal:  J Biol Chem       Date:  1961-07       Impact factor: 5.157

2.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.

Authors:  Colin A Smith; Elizabeth J Want; Grace O'Maille; Ruben Abagyan; Gary Siuzdak
Journal:  Anal Chem       Date:  2006-02-01       Impact factor: 6.986

3.  A flavin-dependent monooxygenase from Mycobacterium tuberculosis involved in cholesterol catabolism.

Authors:  Carola Dresen; Leo Y-C Lin; Igor D'Angelo; Elitza I Tocheva; Natalie Strynadka; Lindsay D Eltis
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

4.  Microbiological degradation of bile acids. Metabolites formed from 3-(3a alpha-hexahydro-7a beta-methyl-1,5-dioxoindan-4 alpha-yl) propionic acid by Streptomyces rubescens.

Authors:  S Hashimoto; S Hayakawa
Journal:  Biochem J       Date:  1977-06-15       Impact factor: 3.857

5.  Carbon-13 NMR studies on cholesterol biosynthesized from [13C]mevalonates.

Authors:  G Popják; J Edmond; F A Anet; N R Easton
Journal:  J Am Chem Soc       Date:  1977-02-02       Impact factor: 15.419

6.  New dehydroxylation reaction observed in the microbiological degradation pathway of cholic acid.

Authors:  S Hayakawa; Y Kanematsu; T Fujiwara
Journal:  Nature       Date:  1967-04-29       Impact factor: 49.962

7.  Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.

Authors:  J D McKinney; K Höner zu Bentrup; E J Muñoz-Elías; A Miczak; B Chen; W T Chan; D Swenson; J C Sacchettini; W R Jacobs; D G Russell
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

8.  Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase.

Authors:  Xinxin Yang; Eugenie Dubnau; Issar Smith; Nicole S Sampson
Journal:  Biochemistry       Date:  2007-07-14       Impact factor: 3.162

9.  The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development.

Authors:  R van der Geize; A W F Grommen; G I Hessels; A A C Jacobs; L Dijkhuizen
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

10.  Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis.

Authors:  Katherine C Yam; Igor D'Angelo; Rainer Kalscheuer; Haizhong Zhu; Jian-Xin Wang; Victor Snieckus; Lan H Ly; Paul J Converse; William R Jacobs; Natalie Strynadka; Lindsay D Eltis
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

View more
  44 in total

Review 1.  The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage.

Authors:  Brian C VanderVen; Lu Huang; Kyle H Rohde; David G Russell
Journal:  Microbiol Spectr       Date:  2016-12

2.  Characterization of novel acyl coenzyme A dehydrogenases involved in bacterial steroid degradation.

Authors:  Amanda Ruprecht; Jaymie Maddox; Alexander J Stirling; Nicole Visaggio; Stephen Y K Seah
Journal:  J Bacteriol       Date:  2015-02-02       Impact factor: 3.490

3.  The Nitrogen Regulator GlnR Directly Controls Transcription of the prpDBC Operon Involved in Methylcitrate Cycle in Mycobacterium smegmatis.

Authors:  Wei-Bing Liu; Xin-Xin Liu; Meng-Jia Shen; Guo-Lan She; Bang-Ce Ye
Journal:  J Bacteriol       Date:  2019-03-26       Impact factor: 3.490

Review 4.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

Review 5.  Updating and curating metabolic pathways of TB.

Authors:  Richard A Slayden; Mary Jackson; Jeremy Zucker; Melissa V Ramirez; Clinton C Dawson; Rebecca Crew; Nicole S Sampson; Suzanne T Thomas; Neema Jamshidi; Peter Sisk; Ron Caspi; Dean C Crick; Michael R McNeil; Martin S Pavelka; Michael Niederweis; Axel Siroy; Valentina Dona; Johnjoe McFadden; Helena Boshoff; Jocelyne M Lew
Journal:  Tuberculosis (Edinb)       Date:  2013-02-01       Impact factor: 3.131

6.  The steroid side-chain-cleaving aldolase Ltp2-ChsH2DUF35 is a thiolase superfamily member with a radically repurposed active site.

Authors:  Rebecca Aggett; Evan Mallette; Stephanie E Gilbert; Melody A Vachon; Kurt L Schroeter; Matthew S Kimber; Stephen Y K Seah
Journal:  J Biol Chem       Date:  2019-06-16       Impact factor: 5.157

7.  A highly conserved mycobacterial cholesterol catabolic pathway.

Authors:  Esther García-Fernández; Daniel J Frank; Beatriz Galán; Petrea M Kells; Larissa M Podust; José L García; Paul R Ortiz de Montellano
Journal:  Environ Microbiol       Date:  2013-03-14       Impact factor: 5.491

8.  Mycobacterium tuberculosis Exploits a Heterohexameric Enoyl-CoA Hydratase Retro-Aldolase Complex for Cholesterol Catabolism.

Authors:  Tianao Yuan; Meng Yang; Kalle Gehring; Nicole S Sampson
Journal:  Biochemistry       Date:  2019-10-07       Impact factor: 3.162

9.  The essential function of genes for a hydratase and an aldehyde dehydrogenase for growth of Pseudomonas sp. strain Chol1 with the steroid compound cholate indicates an aldolytic reaction step for deacetylation of the side chain.

Authors:  Johannes Holert; Nina Jagmann; Bodo Philipp
Journal:  J Bacteriol       Date:  2013-05-24       Impact factor: 3.490

10.  Degradation of the acyl side chain of the steroid compound cholate in Pseudomonas sp. strain Chol1 proceeds via an aldehyde intermediate.

Authors:  Johannes Holert; Žarko Kulić; Onur Yücel; Vemparthan Suvekbala; Marc J-F Suter; Heiko M Möller; Bodo Philipp
Journal:  J Bacteriol       Date:  2012-11-30       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.